KOL Management
Maximising the efficacy of your KOL engagement cycle
Maximising the efficacy of your KOL engagement cycle
New CEO poaches Luke Miels from rival
Corporate development head Lars Jorgensen to take over.
Bio-medicines chief Ricks to take over.